戻る Agenda
Session 4: Egypt Townhall
Session Chair(s)
Dalia Abou Hussein
Quality Assurance (QA) General Director, Egyptian Drug Authority (EDA), Egypt
In this session hosted by the Egyptian Drug Authority (EDA), Egyptian authorities will present the vision for 2030, opportunities and latest developments in the country.
Speaker(s)
Aiman S. El-Khatib
Vice President, Egyptian Drug Authority (EDA), Egypt
EDA’s Establishment and Efforts towards Alignment with International Standards
Yasin Ragaey
Chairman Assistant for Media affairs & Investment Support in the Pharma Sector, Egyptian Drug Authority (EDA), Egypt
EDA Efforts on Investment and Localization within the regulatory framework
Asmaa Fouad
Head Central Adm. of Biological, Innov. Products & Clinical Trials, Egyptian Drug Authority, Egypt
EDA’s path towards International Standards
Medhat Al-Ghobashy
Former EDA Advisor for Regulatory & Reference Labs, Egyptian Drug Authority (EDA), Egypt
Riad Armanious
Vice chairman, Chamber of Pharmaceutical Industry & CEO,, EVA Pharma, Egypt
EDA’s collaborative initiatives
Representative Invited
, EFRP, Egypt
EDA’s collaborative initiatives